20-Year Data Link High-Dose Chemotherapy and Hematopoietic Stem Cell Transplant to Survival Benefit in High-Risk Early Breast Cancer

Adjuvant high-dose chemotherapy HDCT with hematopoietic stem cell transplant HSCT may be beneficial for patients with breast cancer and more than 9 involved axially lymph nodes ALN according to a study presented at the 2018 ESMO Congress in Munich Germany [...]

Acupuncture Reduces Aromatase Inhibitor Joint Pain in Women with Breast Cancer

According to a well designed study presented at the 2017 San Antonio Breast Cancer Symposium acupuncture is effective in reducing pain and stiffness associated with aromatase inhibitor AI therapy in women with early-stage breast cancer1 Stiffness and join [...]

Kisqali® Improves Outcomes of Premenopausal Women with HR+/HER2- Advanced Breast Cancer

It was announced today that results from the Phase III MONALEESA-7 trial evaluating Kisqali ribociclib in combination endocrine-based therapy in premenopausal or perimenopausal women with hormone-receptor positive human epidermal growth factor receptor-2 [...]